Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ZBH	ZIMMER BIOMET HOLDINGS INC	$18.84B	7.30%	4.20%	6.45%	11.80%	0.79	2.44	71.10%	11.90%	16.66%
RGEN	REPLIGEN CORP	$6.92B	-1.20%	-0.80%	-0.07%	-0.10%	0.44	6.79	44.40%	-3.50%	-0.28%
TXG	10X GENOMICS INC	$1.08B	-21.90%	-17.00%	-19.28%	-30.90%	0.28	5.37	68.40%	-25.10%	-24.56%
ATEC	ALPHATEC HOLDINGS INC	$1.78B	N/A	-21.50%	-22.00%	-15.30%	-10.14	2.76	69.00%	-25.80%	-21.50%
BMGL	BASEL MEDICAL GROUP LTD	N/A	N/A	N/A	N/A	N/A	1.16	N/A	77.60%	20.60%	25.68%
NBIX	NEUROCRINE BIOSCIENCES INC	$11.45B	11.80%	8.60%	14.73%	14.60%	0.45	3.13	98.50%	12.70%	19.32%
IMAB	I-MAB	$71.76M	-10.10%	-7.70%	-10.88%	-31.30%	0.06	20.90	N/A	N/A	N/A
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$31.99B	25.90%	6.60%	13.49%	19.70%	2.63	0.98	42.00%	11.00%	16.09%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.79B	-7.50%	-4.00%	-6.82%	-17.90%	0.74	1.54	26.40%	-1.70%	-1.69%
TMDX	TRANSMEDICS GROUP INC	$3.77B	21.90%	6.10%	8.23%	7.10%	2.15	9.10	59.50%	10.00%	13.18%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$1.37B	-66.10%	-25.90%	-30.81%	-25.70%	1.68	2.92	62.50%	-74.80%	-68.77%
NRC	NATIONAL RESEARCH CORP	$295.98M	71.30%	18.70%	36.04%	47.00%	3.56	0.54	60.30%	17.10%	24.85%
SNY	SANOFI	$126.06B	7.30%	4.30%	7.56%	18.20%	0.71	1.46	70.20%	12.60%	17.70%
PACS	PACS GROUP INC	$1.59B	N/A	N/A	N/A	N/A	5.80	1.71	N/A	N/A	N/A
HSIC	HENRY SCHEIN INC	$8.35B	11.90%	3.90%	8.91%	12.40%	1.74	1.38	31.60%	3.20%	5.32%
CNMD	CONMED CORP	$1.77B	12.60%	5.20%	9.00%	12.20%	1.35	2.26	56.10%	9.00%	13.77%
OMI	OWENS & MINOR INC	$537.07M	-51.00%	-7.40%	-7.71%	-6.70%	7.51	1.13	20.60%	-3.40%	-2.08%
PCRX	PACIRA BIOSCIENCES INC	$1.16B	-12.90%	-6.60%	-3.95%	-4.10%	0.99	2.42	77.60%	-14.80%	-7.14%
ABEO	ABEONA THERAPEUTICS INC	$255.77M	-165.40%	-58.20%	-64.46%	-63.50%	1.47	6.08	N/A	N/A	N/A
XOMA	XOMA ROYALTY CORP	$289.77M	-22.10%	-8.50%	-5.64%	-5.90%	1.70	5.15	100.00%	-67.70%	-39.00%
BHC	BAUSCH HEALTH COMPANIES INC	$1.70B	N/A	-0.20%	7.19%	6.30%	-22.54	1.35	70.80%	-0.40%	16.37%
CORT	CORCEPT THERAPEUTICS INC	$7.45B	20.40%	16.60%	15.55%	19.70%	0.24	3.07	98.40%	19.30%	15.95%
ELAN	ELANCO ANIMAL HEALTH INC	$5.94B	6.00%	2.80%	6.38%	9.70%	1.04	2.71	54.90%	8.40%	16.83%
ISRG	INTUITIVE SURGICAL INC	$192.29B	15.50%	13.70%	15.76%	21.60%	0.12	4.98	67.10%	28.40%	31.97%
ITGR	INTEGER HOLDINGS CORP	$4.13B	4.80%	2.40%	5.39%	7.30%	1.05	3.40	27.00%	4.40%	9.49%
TLX	TELIX PHARMACEUTICALS LTD	$5.75B	13.90%	5.20%	7.84%	27.90%	1.67	2.78	65.10%	6.40%	11.87%
BIO	BIO-RAD LABORATORIES INC	$6.50B	-31.50%	-22.10%	-29.95%	-28.40%	0.43	5.99	53.50%	-85.20%	-106.32%
NVAX	NOVAVAX INC	$967.77M	-115.50%	30.00%	58.59%	244.30%	-18.09	2.06	87.40%	38.10%	40.66%
HQY	HEALTHEQUITY INC	$7.82B	4.60%	2.80%	5.37%	14.10%	0.63	3.06	64.80%	8.10%	14.73%
WEAV	WEAVE COMMUNICATIONS INC	$784.15M	-43.70%	-15.80%	-24.85%	-23.60%	1.75	1.60	71.80%	-14.10%	-13.21%
MDGL	MADRIGAL PHARMACEUTICALS INC	$6.54B	-50.50%	-37.20%	-45.51%	-50.30%	0.40	5.91	96.60%	-123.40%	-118.93%
FOLD	AMICUS THERAPEUTICS INC	$1.84B	-16.80%	-3.80%	7.13%	7.10%	3.08	3.34	90.60%	-5.40%	8.36%
IRWD	IRONWOOD PHARMACEUTICALS INC	$114.72M	-0.30%	0.20%	31.48%	11.80%	-2.17	4.70	100.00%	0.30%	27.95%
HSTM	HEALTHSTREAM INC	$849.82M	5.40%	3.80%	5.90%	39.10%	0.44	1.35	66.20%	6.50%	8.04%
GKOS	GLAUKOS CORP	$5.14B	-17.30%	-13.10%	-12.83%	-20.70%	0.27	6.49	75.80%	-30.60%	-28.48%
SLP	SIMULATIONS PLUS INC	$603.73M	3.90%	3.70%	4.47%	34.80%	0.06	4.37	55.30%	9.20%	10.86%
DOMH	DOMINARI HOLDINGS INC	$37.59M	-35.00%	-30.70%	-33.92%	-33.10%	0.18	7.44	100.00%	-81.00%	-81.03%
LEGN	LEGEND BIOTECH CORP	$5.83B	-15.80%	-10.10%	-9.80%	-21.80%	0.61	4.62	62.60%	-28.20%	-21.76%
ABT	ABBOTT LABORATORIES	$231.82B	30.60%	17.40%	11.55%	19.60%	0.66	1.78	55.80%	31.90%	18.67%
SENS	SENSEONICS HOLDINGS INC	$408.93M	-14,516.50%	-74.80%	-87.28%	-86.10%	1.48	6.88	7.20%	-312.50%	-279.45%
UTMD	UTAH MEDICAL PRODUCTS INC	$175.91M	11.20%	10.70%	14.15%	86.00%	0.04	25.64	59.00%	33.90%	41.08%
LNTH	LANTHEUS HOLDINGS INC	$5.66B	22.80%	12.70%	20.80%	34.40%	0.77	5.74	64.00%	16.50%	24.46%
FONR	FONAR CORP	$81.60M	4.40%	3.50%	6.12%	6.80%	0.29	11.24	41.50%	7.20%	11.79%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$221.79M	7.80%	5.70%	10.10%	18.00%	0.36	4.52	74.60%	5.50%	8.44%
ACAD	ACADIA PHARMACEUTICALS INC	$2.92B	35.30%	21.70%	31.92%	64.00%	0.48	2.88	92.00%	23.00%	26.58%
IQV	IQVIA HOLDINGS INC	$25.78B	20.70%	4.90%	11.50%	17.90%	3.57	0.82	34.70%	8.60%	14.94%
ACB	AURORA CANNABIS INC	$266.16M	-3.90%	-2.60%	-0.94%	-1.20%	0.44	3.30	61.50%	-5.60%	-1.71%
CERT	CERTARA INC	$1.94B	-0.20%	-0.20%	0.92%	4.10%	0.44	2.78	60.30%	-0.70%	3.39%
MRK	MERCK & CO INC	$190.76B	38.20%	15.10%	23.83%	28.50%	1.38	1.41	76.40%	27.30%	33.53%
EUDA	EUDA HEALTH HOLDINGS LTD	$144.15M	N/A	-1,021.00%	626.82%	513.40%	-1.67	0.18	19.00%	-382.90%	-381.87%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$1.14B	19.40%	9.10%	14.07%	15.90%	1.17	2.95	50.50%	19.40%	27.48%
NTRA	NATERA INC	$20.75B	-18.30%	-11.70%	-13.23%	-25.70%	0.40	3.87	61.80%	-10.40%	-9.87%
ENTA	ENANTA PHARMACEUTICALS INC	$112.42M	-75.50%	-27.30%	-32.38%	-20.90%	2.12	5.47	100.00%	-157.60%	-145.67%
CBLL	CERIBELL INC	$572.82M	N/A	N/A	-18.11%	N/A	0.18	16.73	86.70%	-61.80%	-58.77%
BRKR	BRUKER CORP	$5.69B	4.40%	1.30%	3.49%	3.80%	2.24	1.57	49.00%	2.30%	4.64%
GYRE	GYRE THERAPEUTICS INC	$893.51M	11.40%	5.80%	9.86%	11.80%	0.37	3.60	96.20%	7.20%	10.86%
USPH	U S PHYSICAL THERAPY INC	$1.13B	6.80%	3.00%	5.39%	13.50%	0.85	1.17	18.10%	4.80%	8.14%
INGN	INOGEN INC	$167.78M	-14.80%	-9.00%	-11.53%	-28.50%	0.56	3.07	46.10%	-8.10%	-8.24%
ALKS	ALKERMES PLC	$4.97B	25.40%	16.60%	26.61%	31.40%	0.38	3.33	84.40%	23.30%	28.80%
INMD	INMODE LTD	$993.58M	25.00%	22.20%	22.13%	24.10%	0.14	8.74	80.00%	44.80%	35.64%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	N/A	N/A	N/A	169.54%	N/A	-1.62	0.25	100.00%	-14,335.50%	-11,254.71%
MEDP	MEDPACE HOLDINGS INC	$8.51B	54.40%	20.80%	59.41%	-226.70%	2.20	0.73	31.50%	19.30%	21.35%
MGTX	MEIRAGTX HOLDINGS PLC	$427.39M	-161.80%	-51.60%	-64.37%	-65.50%	2.98	2.03	28.50%	-444.10%	-404.22%
CON	CONCENTRA GROUP HOLDINGS PARENT INC	$2.74B	29.70%	6.20%	12.42%	12.80%	7.81	1.10	28.00%	8.10%	15.48%
VALN	VALNEVA SE	$525.35M	-43.40%	-16.40%	-14.69%	-13.40%	1.75	2.70	46.60%	-43.20%	-29.69%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.12B	-1,337.40%	-15.90%	-22.94%	-16.90%	8.87	1.26	97.00%	-41.30%	-33.71%
TBPH	THERAVANCE BIOPHARMA INC	$444.25M	-29.70%	-15.60%	-13.06%	-12.30%	1.02	5.02	100.00%	-87.60%	-65.34%
BFLY	BUTTERFLY NETWORK INC	$551.45M	-33.00%	-23.30%	-22.98%	-46.50%	0.33	6.06	60.70%	-75.60%	-74.07%
HAE	HAEMONETICS CORP	$3.43B	14.20%	5.30%	7.92%	9.30%	1.79	3.97	53.30%	9.50%	13.14%
FHTX	FOGHORN THERAPEUTICS INC	$233.57M	N/A	-29.50%	-39.92%	-44.90%	-7.24	3.73	100.00%	-383.20%	-383.24%
KRYS	KRYSTAL BIOTECH INC	$3.82B	13.60%	12.30%	13.87%	23.50%	0.09	9.65	93.20%	37.20%	41.39%
AMWL	AMERICAN WELL CORP	$108.14M	-47.60%	-33.50%	-48.83%	-1,751.20%	0.39	2.92	44.30%	-59.10%	-58.35%
CRON	CRONOS GROUP INC	$763.13M	4.60%	4.30%	-0.12%	-0.60%	0.04	27.80	27.70%	39.70%	-1.07%
MYNZ	MAINZ BIOMED NV	$5.68M	-465.80%	-151.20%	-282.30%	-1,734.30%	1.19	1.32	64.30%	-2,421.80%	-2,301.53%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$1.61B	-80.70%	-32.90%	-42.08%	-29.80%	1.41	3.55	88.40%	-61.00%	-50.02%
MYGN	MYRIAD GENETICS INC	$358.57M	-14.10%	-9.70%	-14.48%	-33.40%	0.43	1.90	70.00%	-12.20%	-14.89%
ASRT	ASSERTIO HOLDINGS INC	$58.42M	-16.70%	-7.70%	-10.87%	-25.00%	1.35	1.77	68.60%	-17.30%	-14.80%
OGN	ORGANON & CO	$2.26B	181.70%	5.90%	11.24%	9.50%	23.27	1.67	57.20%	11.90%	18.83%
IBRX	IMMUNITYBIO INC	$1.77B	N/A	-103.90%	-79.04%	-23.20%	-1.78	3.36	100.00%	-2,804.80%	-1,758.13%
VTRS	VIATRIS INC	$10.29B	-20.60%	-8.90%	-10.37%	-14.20%	1.46	1.68	36.90%	-26.40%	-23.71%
AORT	ARTIVION INC	$1.23B	-7.30%	-2.70%	1.56%	1.90%	1.69	5.53	63.90%	-5.50%	2.95%
SSII	SS INNOVATIONS INTERNATIONAL INC	N/A	-132.40%	-51.20%	-86.34%	-66.70%	2.15	1.29	40.90%	-92.70%	-88.03%
SIGA	SIGA TECHNOLOGIES INC	$404.36M	25.20%	22.10%	28.40%	97.70%	0.14	8.40	76.50%	40.30%	51.76%
MESO	MESOBLAST LTD	$1.26B	-21.30%	-15.60%	-13.73%	-79.50%	0.42	0.96	100.00%	-1,822.80%	-1,405.84%
TMO	THERMO FISHER SCIENTIFIC INC	$152.18B	13.30%	6.60%	9.69%	15.80%	1.01	1.78	41.30%	15.20%	19.39%
ACRS	ACLARIS THERAPEUTICS INC	$136.43M	-92.40%	-68.40%	-73.74%	-94.90%	0.38	5.06	14.90%	-732.40%	-732.42%
PVLA	PALVELLA THERAPEUTICS INC	$250.90M	-58.30%	-42.70%	-17.21%	606.80%	0.41	7.33	N/A	N/A	N/A
DVAX	DYNAVAX TECHNOLOGIES CORP	$1.13B	-9.80%	-6.00%	-5.55%	-4.40%	0.78	11.93	82.30%	-20.40%	-16.54%
ATR	APTARGROUP INC	$10.13B	14.90%	8.20%	15.57%	21.80%	0.78	1.25	38.20%	10.40%	14.54%
QIPT	QUIPT HOME MEDICAL CORP	$93.94M	-6.70%	-2.90%	-0.20%	-0.20%	1.28	1.22	20.70%	-3.00%	-0.15%
SGRY	SURGERY PARTNERS INC	$2.83B	-8.80%	-2.20%	2.32%	3.20%	2.62	1.79	23.90%	-5.40%	5.40%
CERS	CERUS CORP	$246.60M	-35.30%	-9.70%	-7.29%	-4.70%	2.71	2.32	60.60%	-9.20%	-4.83%
CLLS	CELLECTIS SA	$44.24M	-29.40%	-9.50%	-6.97%	-9.00%	1.93	1.73	100.00%	-74.70%	-30.78%
ANIK	ANIKA THERAPEUTICS INC	$165.01M	-30.00%	-23.50%	-29.35%	-31.60%	0.32	4.88	63.40%	-47.00%	-43.92%
CVAC	CUREVAC NV	$778.45M	28.90%	22.30%	26.24%	78.80%	0.15	7.28	80.20%	30.30%	35.82%
EXAS	EXACT SCIENCES CORP	$9.74B	-36.40%	-16.30%	-19.19%	-25.00%	1.38	2.73	69.00%	-36.10%	-35.35%
CANF	CAN-FITE BIOPHARMA LTD	$9.93M	-134.90%	-82.50%	-111.49%	-259.30%	0.68	4.38	100.00%	-1,169.10%	-1,169.14%
MCRB	SERES THERAPEUTICS INC	$61.61M	26,673.10%	36.30%	57.50%	39.10%	2.25	2.11	N/A	N/A	N/A
RDY	DR REDDYS LABORATORIES LTD	$11.18B	21.80%	15.70%	25.24%	31.20%	0.38	2.58	58.60%	19.90%	26.36%
FLGT	FULGENT GENETICS INC	$599.74M	-3.60%	-3.30%	-4.24%	-5.20%	0.07	6.32	38.80%	-13.90%	-16.54%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	661	-1.90%	-9.32%	+2.11%	-77.89%	-159.67x	4.11x	-21.63%	-3.01%	+4.31%	+117.15%	Strong Buy
Diagnostics & Research	58	-1.82%	-1.68%	+1.10%	-27.12%	30.54x	3.32x	-9.95%	+6.16%	+11.85%	+24.70%	Buy
Drug Manufacturers - General	18	-1.71%	-7.73%	-2.94%	-10.66%	36.28x	5.66x	+50.81%	+9.81%	+16.71%	+64.13%	Buy
Drug Manufacturers - Specialty & Generic	78	+11.46%	+24.26%	+37.21%	-44.14%	4.37x	2.16x	+10.84%	+5.55%	+11.97%	+47.21%	Buy
Healthcare Plans	11	-1.10%	-1.32%	-12.70%	-17.24%	15.61x	2.29x	+17.32%	+5.46%	+12.61%	+24.91%	Buy
Health Information Services	55	+0.01%	-1.23%	+3.09%	-69.80%	45.44x	3.60x	+9.15%	+3.87%	+8.90%	+56.84%	Buy
Medical Care Facilities	48	+0.29%	+1.20%	+2.81%	-13.81%	15.73x	4.39x	-79.34%	+6.65%	+14.02%	+20.85%	Buy
Medical Devices	142	+0.75%	+1.23%	+4.30%	-16.99%	37.31x	3.97x	+8.00%	+8.35%	+9.21%	+31.00%	Strong Buy
Medical Distribution	10	+0.25%	-1.88%	+4.46%	+22.12%	27.32x	1,280.97x	-0.01%	+3.61%	+22.85%	+7.41%	Buy
Medical Instruments & Supplies	55	-0.60%	-0.13%	+0.08%	-41.35%	42.59x	3.69x	+10.11%	+8.34%	+10.85%	+28.79%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 26, which is equal to the healthcare sector average of 26. It passed 8 out of 33 due diligence checks and has average fundamentals. Protalix Biotherapeutics has seen its stock return 37.6% over the past year, overperforming other healthcare stocks by 93 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 772.09% from Protalix Biotherapeutics's current stock price of $1.72.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #2 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 38, which is 12 points higher than the healthcare sector average of 26. It passed 12 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 42.45% over the past year, overperforming other healthcare stocks by 98 percentage points.

Ptc Therapeutics has an average 1 year price target of $61.85, an upside of 39.83% from Ptc Therapeutics's current stock price of $44.23.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 46.15% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a Hold, while 0% have issued a Sell rating, and 15.38% have issued a Strong Sell.

3. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #3 top healthcare stock out of 1136 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 42, which is 16 points higher than the healthcare sector average of 26. It passed 15 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 26.95% over the past year, overperforming other healthcare stocks by 83 percentage points.

Phibro Animal Health has an average 1 year price target of $21.50, a downside of -4.32% from Phibro Animal Health's current stock price of $22.47.

Phibro Animal Health stock has a consensus Sell recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 0% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Jade Biosciences (NASDAQ:JBIO)

Jade Biosciences (NASDAQ:JBIO) has an annual dividend yield of 27.75%, which is 25 percentage points higher than the healthcare sector average of 2.45%.

Jade Biosciences's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.16%, which is 11 percentage points higher than the healthcare sector average of 2.45%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

3. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.6%, which is 8 percentage points higher than the healthcare sector average of 2.45%.

Siga Technologies's dividend payout ratio of 88.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.43% in the last day, and down -2.62% over the last week. Iovance Biotherapeutics was the among the top losers in the healthcare sector, dropping -44.79% yesterday.

Iovance Biotherapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results. Also, HC Wainwright lowered its price target on the spot from $32 to $20.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Biote (NASDAQ:BTMD)

Biote (NASDAQ:BTMD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Biote has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Biote's stock has dropped -36% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 8.86% in the past year. It has overperformed other stocks in the healthcare sector by 65 percentage points.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 14, which is -2 points higher than the healthcare sector average of 16. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates IRWD a Valuation Rating of "A".

Ironwood Pharmaceuticals's stock has dropped -89.48% in the past year. It has underperformed other stocks in the healthcare sector by -34 percentage points.

Are healthcare stocks a good buy now?

52.64% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 55.23% over the next year.

5.2% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.88% of healthcare stocks are rated B (Buy), 45.22% are rated C (Hold), 26.72% are rated D (Sell), and 11.97% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 3.99x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Protalix Biotherapeutics (NYSEMKT:PLX)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Phibro Animal Health (NASDAQ:PAHC)

1. Jade Biosciences (NASDAQ:JBIO)

2. Select Medical Holdings (NYSE:SEM)

3. Siga Technologies (NASDAQ:SIGA)

1. Biote (NASDAQ:BTMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Protalix Biotherapeutics (NYSEMKT:PLX)

2. Ptc Therapeutics (NASDAQ:PTCT)

3. Phibro Animal Health (NASDAQ:PAHC)

1. Jade Biosciences (NASDAQ:JBIO)

2. Select Medical Holdings (NYSE:SEM)

3. Siga Technologies (NASDAQ:SIGA)

1. Biote (NASDAQ:BTMD)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.